Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting
-
Rapid7 Appoints Wael Mohamed Chief Executive Officer; Corey Thomas to Become Executive Chairman
-
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
-
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.085 Per Share for June 2026
-
Vedder Adds Depth to Washington DC Office With Addition of Life Sciences Attorney Melissa Gilmore
-
Aldebaran Announces Execution of Arrangement Agreement for Spin-Out of Centauri Minerals Inc.
-
Canadian Life Companies Split Corp. Announces TSX Acceptance of Normal Course Issuer Bid
-
PMGC Holdings Signs Non-Binding Letter of Intent to Acquire Majority Stake in U.S.-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, and Semiconductor Markets
-
Cognition Therapeutics Participating in Upcoming Investor Conferences
-
Brixton Metals Drills 2.3 m of 1,811 g/t Silver within 27.7 m of 166.45 g/t Silver at its Langis Project
-
Dividend 15 Split Corp. Announces TSX Acceptance of Normal Course Issuer Bid
-
Financial 15 Split Corp. Announces TSX Acceptance of Normal Course Issuer Bid
-
TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology
-
North American Financial 15 Split Corp. Announces TSX Acceptance of Normal Course Issuer Bid
-
Nayax Launches AI-Powered Product Discovery for Retailers
-
Canadian Banc Corp. Announces TSX Acceptance of Normal Course Issuer Bid
-
Dividend 15 Split Corp. II Announces TSX Acceptance of Normal Course Issuer Bid
-
SL Green Announces the Sale of 10 East 53rd Street
-
Belo Sun Announces Corporate Update
-
Generali Expands Deployment of Intermap's AI-Enabled Risk Platform in Central and Eastern Europe
-
Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026
-
DEEP SEA MINERALS CORP. ACHIEVES SUBSTANTIAL COMPLIANCE DETERMINATION FROM NOAA UNDER DSHMRA FOR SEABED MINERAL CONCESSIONS
-
Anterix Sets Fourth Quarter Fiscal 2026 Earnings Conference Call for Thursday, June 11, at 9:00 a.m. ET
-
Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001
-
XCharge Appoints Albina Iljasov as Co-Chief Executive Officer
-
TechForce Robotics Enters Pharmaceutical Automation Market Through Initial Deployment at Oncotelic Therapeutics
-
BriaCell Presents Positive Clinical Data at ASCO 2026
-
HCI Group Announces Completion of its 2026-2027 Catastrophe Reinsurance Programs
-
Athene Announces Key Leadership Appointment
-
Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO
-
Vireo Growth Inc. Announces Share Consolidation
-
Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York
-
OptimizeRx to Participate in Upcoming Investor Conferences
-
Mattr Appoints New Director
-
Generali Expands Deployment of Intermap's AI-Enabled Risk Platform in Central and Eastern Europe
-
Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany
-
Otherwander Opens in the Heart of Soho, London
-
Canadian Author Grows Hope with the Launch of Don't Let Ned Plant a Tree THERE! on International Children's Day
-
Canadian Author Grows Hope with the Launch of Don't Let Ned Plant a Tree THERE! on International Children's Day
-
Ninth Circuit Anticipated to Rule on UnitedHealthcare’s Alleged Deceptive Medicare Advantage Advertising Practices - GJLaw
-
FLUENT Reports First Quarter 2026 Results
-
New Era Energy & Digital Announces Upcoming Conference Participation and Expected Russell Index Inclusion
-
New Era Energy & Digital Announces Upcoming Conference Participation and Expected Russell Index Inclusion
-
Edible Garden Accelerates Path to Profitability Through Major Logistics Transformation, Reducing Operating Costs, Lowering Emissions and Enhancing Supply Chain Efficiency
-
Novo Nordisk A/S - share repurchase programme
-
DELPHX ANNOUNCES CLOSING OF CONVERTIBLE DEBENTURE
-
Richardson Hartley Law and Humphries Kerstetter to pursue Meta for role in multi-billion scam ad scandal through group legal action
-
Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML
-
Piedmont REIT Signs 240,000 SF of Leases Second Quarter-to-Date Bringing YTD Leasing to approximately 670,000 SF
-
Piedmont REIT Signs 240,000 SF of Leases Second Quarter-to-Date Bringing YTD Leasing to approximately 670,000 SF
